Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
about
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsPharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Isavuconazole: is there a need for a new antifungal?Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14 C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.
P2860
Q28067726-86FEBA76-4F92-440E-A6DE-F435B8CEFE63Q37631771-6EB87A5A-5F14-48C7-ACDC-C04517AD2A80Q37631831-EBC49614-1B99-4F52-B763-7B0E565ABD60Q39443748-B5715AE3-BA25-445A-9968-FE7A70D16B04Q40273512-1DD91D73-A03B-46E0-90A8-C095F8EC5D19Q42323175-DD385BB5-79DC-43AA-8127-1DCEBB9D73CAQ45069532-DCA572C4-9BAC-4C6F-A473-3DB8925B7F48Q47151374-D6069D6A-010D-42D6-B869-80EFBDEABC5EQ47954619-976B9E47-70A4-4330-8481-4F6FECD0A1A1
P2860
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@en
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@nl
type
label
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@en
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@nl
prefLabel
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@en
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic Interactions B ...... hotrexate in Healthy Subjects.
@en
P2093
Amit Desai
Christopher Lademacher
Corrie Howieson
Diane Rammelsberg
Donna Kowalski
Kenneth C Lasseter
Robert Townsend
Ronald Goldwater
Shahzad Akhtar
P2860
P356
10.1002/CPDD.280
P577
2016-06-08T00:00:00Z